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The hydrolysis of inositol [32P]trisphosphate (IP,) and inositol [32P]bisphosphate (IP,) has been examined 
in subcellular fractions of rat liver. IP, was degraded by an enzyme located in the plasma membrane which 
did not degrade IP,. Cytosolic fractions were found to degrade both IP, and IP,. The IP, phosphatase activi- 
ty of liver plasma membranes displayed a neutral pH optimum, was Mg2+ dependent and was not inhibited 
by high concentrations of Li’. Half-maximal activity of the enzymes hydrolysing IP, and IP, was obtained 
with substrate concentrations in the range l-2 PM. The significance of these observations to the proposed 
Ca2+-mobilizing role of IP, is discussed. 
Inositol trisphosphate Inositol lipid 
1. INTRODUCTION 
The addition of myo-inositol 1,4,5trisphos- 
phate (IP3) to a variety of different permeabilized 
cell types has been found to induce the rapid 
release of Ca 2+ from a non-mitochondrial, in- 
tracellular store (review, [l]). These observations, 
taken together with the finding that this compound 
accumulates in cells stimulated with Ca2’-mobi- 
lizing agOniStS, StrOngly Suggest that IP3 may act as 
an intracellular messenger mediating the effects of 
a large number of hormones and neurotransmitters 
whose mode of action involves an increase in the 
cytoplasmic free Ca2+ concentration [2,3]. The ac- 
cumulation of IP3 observed upon receptor occupa- 
tion is thought to reflect the increased activity of a 
phosphodiesterase (phospholipase C) acting upon 
phosphatidylinositol4$bisphosphate (PIP2). Ter- 
mination of the response, i.e., by displacement of 
the hormone from its receptor, promotes the 
return of IP3 levels to control values [4,5]. It has 
been inferred that enzymes are present in these 
cells which can degrade IP3 but the subcellar site of 
this degradation or the regulatory properties of 
these enzymes have not been studied. Further sup- 
port for the presence of an enzyme catalysing IP3 
Phosphatase Magnesium Calcium 
hydrolysis stems from the finding that the slow re- 
uptake of Ca2+ released by IP3 from the 
permeabilized hepatocyte correlates with the disap- 
pearance of this compound from the incubation 
medium [6]. Erythrocytes have been shown to 
possess an enzyme that can specifically degrade in- 
ositol 1,4$trisphosphate to produce inositol 
1,Cbisphosphate (IP2) [7]. A similar activity has 
also been observed in homogenates of insect 
salivary gland [8] and iris smooth muscle [9]. Here, 
we have utilized 32P-labeled IP3 and IP2 to examine 
the subcellular distribution of the phosphatases 
acting on these substrates in rat liver. Our findings 
indicate that distinct enzymes are present in the 
plasma membrane and soluble fractions of the cell 
which can hydrolyze IP3 and IPz, respectively. 
Some properties of these enzymes are described. 
2. MATERIALS AND METHODS 
32P-labeled IP3 and IP2 were prepared from their 
respective inositol-lipid precursors by phospholip- 
ase C-mediated hydrolysis of human erythrocyte 
membranes as described by Downes et al. [7]. The 
phospholipids were prelabeled by incubating the 
washed erythrocytes with “P for 12 h at 30°C as 
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described by Downes and Michell [lo]. It should be 
pointed out that in the erythrocyte this procedure 
labels only the monoester phosphates of the 
polyphosphoinositides (4 and 5 positions) without 
labeling the diester phosphate [7, lo]. The concen- 
trations of inositol polyphosphates were deter- 
mined by measurement of phosphate content after 
perchloric acid digestion [ 111. The basic incubation 
medium (pH 7.2, 30°C) used to incubate the 
various subcellular fractions contained, in addition 
to the labeled substrates, the following com- 
ponents (mM): KC1 (1 lo), NaCl (lo), KHzP04 (I), 
K+-Hepes (20) and MgCl2 (3). Aliquots (0.25 ml) 
were removed at appropriate times and depro- 
teinized with 0.25 ml of ice-cold trichloracetic acid 
(20%, w/v). After removal of precipitated protein 
by centrifugation, the supernatant was diluted with 
1 ml of water, neutralized and loaded onto small 
(approx. 0.6 ml) columns of Dowex-I (formate 
form). Inorganic phosphate, IP2 and the IPs were 
sequentially eluted from the column as described 
previously [4]. 
Plasma membranes were prepared using isotonic 
Percoll gradients as described by Prpic et al. [12]. 
Other fractions were prepared by differential cen- 
trifugation of a 10% (w/v) liver homogenate 
prepared in 0.25 M sucrose and 20 mM Tris-Hepes 
(pH 7.2). Mitochondria were isolated from this 
homogenate as described previously [ 131. The 
post-mitochondrial supernatant was centrifuged at 
65 000 x g and the resulting pellet and supernatant 
was used as the microsomal and cytosolic frac- 
tions, respectively. The following assay methods 
were used for marker enzymes: glutamate 
dehydrogenase [ 141, NADPH-cytochrome c reduc- 
tase [15] and 5’-nucleotidase [16]. 
3. RESULTS AND DISCUSSION 
Subcellular fractions prepared from rat liver 
were tested for their ability to hydrolyze added 32P- 
IP3 and 32P-IP~ (table 1). Plasma membranes con- 
tained the highest specific activity of an enzyme 
degrading IP3. A IO-fold enrichment of this activi- 
ty relative to the homogenate was obtained. The 
cytosolic fraction also contained IP3-phosphatase 
but at a specific activity that was 20-30070 of that 
found in the plasma membrane (table 1, fig. 4). 
Marker enzyme analysis indicates only a 3% con- 
tamination of the cytosolic fraction by plasma 
membranes and this suggests that the cytosolic 
IP3-phosphatase may reflect a genuine, soluble 
Table 1 
Subcellular localization of the phosphatases degrading inositol trisphosphate and mositol bisphosphate in rat liver 
Subcellular 
fraction 
Rate of inositol Plasma membranes, Endoplasmic Mitochondria, 
phosphate degradation 5 ’ -nucleotidase reticulum NADPH- Glutamate 
(nmol/mg protein Cyt c reductase dehydrogenase 
per min) 
Homogenate 
Plasma membranes 
Cytosol 
Endoplasmic 
reticulum 
Mitochondria 
IP3 
0.17 
1.86 
0.35 
0.56 
0.10 
IP2 
0.27 
0 
0.40 
0 
0 
-fold en- % conta- -fold en- % conta- -fold en- % conta- 
richment mination richment mination richment mination 
28.1 - 0.7 27.4 0.03 0.7 
0.9 3.0 0.3 11.8 0.1 1.4 
2.2 7.8 2.5 - 0.3 7.5 
2.1 7.3 0.3 11.5 4.6 
The degradation of 32P-labeled IPs (3 ,uM) and IP2 (6.5 PM) was measured in various subcellular fractions of rat liver. 
The purity of these fractions was assessed by the measurement of marker enzymes. The ‘fold enrichment’ was calculated 
as the ratio of the specific activity of the marker enzyme in a given fraction to the specific activity measured in the 
homogenate. The % cross-contamination was calculated with the assumption that the specific activity of the marker 
enzymes for plasma membranes, ER and mitochondrial fractions represent 100% purity. The results shown are the 
mean of 2 experiments in which the individual values differed by < 15% of the mean. The specific activity of inositol 
polyphosphate hydrolysis was calculated without correction for any impurity of the added substrates 
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form of the enzyme. Similar considerations uggest 
that the IPj-phosphatase activity found in the en- 
doplasmic reticulum and mitochondrial fractions 
can be entirely accounted for by plasma membrane 
contamination. 
The time copurse of the degradation of 1.45 PM 
32P-IP3 by liver plasma membranes and the ac- 
cumulation of products is shown in fig. 1. Aliquots 
of the incubation removed at ‘zero-time’ and 
analyzed by anion exchange chromatography in- 
dicated that almost 90% of the total 32P counts 
eluted as Ip3. This assessment of the radiochemical 
purity of the IP3 was in agreement with results ob- 
tained after thin layer chromatography of Ip3 on 
polyethylenimine cellulose [ 171 (not shown). With 
increasing incubation time, the plasma membranes 
decreased the proportion of counts as IP3 and this 
was accompanied by an increase in the counts pre- 
sent as inorganic phosphate and IP2. Under these 
conditions linear changes were observed over a 2.5 
min interval. It was consistently found that the 
production of Pi exceeded that of IP2. In 5 
separate xperiments the relative ratio of counts in 
Pi and IPz measured after 2 min incubation was 
2.1+ 0.2 (mean + SE). Such a result could arise if 
the IP2 formed from the hydrolysis of IP3 was fur- 
ther dephosphorylated by the plasma membranes. 
An alternative explanation is that the IP3 derived 
from the erythrocyte may not be equally labeled 
with 32P in the 4 and 5 positions of the inositol 
ring, and the plasma membrane nzyme may selec- 
tively cleave only the more highly labeled 
phosphate. Experimental support for the latter ex- 
planation comes from the finding that liver plasma 
membranes were unable to hydrolyse added 32P- 
IP2 (fig. 1B). Table 1 shows that a phosphatase act- 
ing on this compound is located exclusively in the 
soluble fraction of the cell. Both erythrocyte mem- 
branes [7] and salivary gland homogenates [8] also 
release more Pi than IP2 when given erythrocyte 
32P-IP3 as substrate. Recently, Hawkins et al. [18] 
have established that 60-70% of the 32P-label in 
this molecule is present on the phosphate attached 
at the 5 position. Hence, our experimental results 
are compatible with the presence in the liver 
plasma membranes of an IP3-phosphatase that 
selectively removes phosphate from the 5-position 
to produce IP2 which can then be further 
dephosphorylated by a separate cytosolic enzyme. 
The pH dependence of IP3 hydrolysis by plasma 
membranes was measured over the range pH 6-9 
(fig. 2). Optimal activity was obtained at pH 7.0, 
Time (min) 
Fig. 1. Time course of degradation of 32P-Ip3 (A) and 
“P--IF’2 (B) by rat liver plasma membranes. Liver 
plasma membranes (0.7 mg/ml) were incubated with 
“p-Ip3 (1.45 pM; cpm/nmol) and 32P-IP2 (3.5 PM; 720 
CPIIIhInOl). Samples were removed at the indicated 
times, quenched with trichloracetic acid and analyzed 
for reaction products as described in section 2. The 
results shown in (A) are the mean f SD of 4 
determinations and those in (B) are the means of 
I t 
’ 6 
I I I I I 
7 8 9 
PH 
Fig. 2. pH Dependence of IP3 hydrolysis by liver plasma 
membranes. The pH of the normal incubation buffer 
(c.f. section 2) was adjusted to the indicated pH using 
NaOH or HCl. The concentration of IP3 used in the 
duplicate determinations. experiment was 3.6 PM. 
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suggesting that alkaline or acid phosphatases are 
unlikely to be responsible for the IPj 
dephosphorylation catalyzed by plasma mem- 
branes. Further support for the view that 
dephosphorylation of IP3 is not the result of a non- 
specific phosphatase activity comes from the find- 
ing that the hydrolysis of 1.5 ,uM. 32P-IP3 is unaf- 
fected by the presence of 5 mM of either P- 
nitrophenylphosphate or ATP (not shown). 
Fig. 3 shows that the hydrolysis of 32P-IP3 by 
plasma membranes was entirely dependent on the 
presence of Mg2+ in the incubation medium. 
Similar results were obtained for the hydrolysis of 
32P-IP~ by the cytosolic fraction (not shown). The 
concentration of Mg2+ required for half-maximal 
IP3-phosphatase activity was approximately 0.25 
mM (fig. 3). Lithium is known to inhibit the activi- 
ty of inositol l-phosphate phosphatase [19] and 
pretreatment of hepatocytes with this ion causes an 
increase in the accumulation of inositol phosphates 
upon stimulation with vasopressin. A maximal ef- 
fect on IP3 accumulation was obtained with 20 mM 
LiCl [4]. However, 20 mM LiCl had no effect on 
the hydrolysis of IP3 catalyzed by plasma mem- 
branes when tested over a range of IP3 and Mg2+ 
concentrations (not shown). Thus these effects of 
Li+ on IPs accumulation observed in hormone- 
treated hepatocytes is unlikely to be the result of an 
inhibitory effect of Li+ on IPJ-phosphatase. Alter- 
native indirect effects of this cation on inositol 
lipid metabolism remain to be explored. 
50- 
[Mg++] (mM) 
Fig. 4. Concentration dependence of IPs (A) and IPz (B) 
hydrolysis. (A) Liver plasma membranes (0.7 mg 
protein/ml; o-0) or a cytosolic fraction (1.6 mg 
protein/ml; c-o) were incubated with the indicated 
concentrations of 32P-IPs for 2 min. The 32P-phosphate 
released over this interval was measured and is expressed 
as a percentage of the total 32P added’to the incubation. 
The results shown are the mean of 2 experiments or, 
where error bars are shown, the mean&SE of 3 
experiments. (B) The experimental conditions were 
identical except that 32P-IPz was used as the substrate 
Fig. 3. Magnesium dependence of IPs hydrolysis by liver 
plasma membranes. The experimental conditions were 
as described for fig. 1. Each determination was made in 
duplicate and the results shown are the mean of 2-3 
separate experiments. for the enzyme present in the cytosolic fraction. 
The dependence of enzyme activity on the con- 
centration of added IP3 using plasma membranes 
and cytosolic fractions is shown in fig. 4A. 
IPa-phosphatase activity in the cytosolic fraction 
I I , I I 
2 4 6 8 IO'% 
IP2(pM) 
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had a maximum activity that was 30% of that 
found in the plasma membranes. However, both 
fractions required approximately the same concen- 
tration of IPs for half-maximal activity. Double 
reciprocal plots of the data gave values of 1.4 and 
1 .O ,uM, respectively, for the membrane and solu- 
ble forms of the enzyme. Dose-response studies 
were carried out with IP2 as a substrate for the en- 
zyme activity present in the cytosolic fraction (fig. 
4B). Maximal activity of this enzyme was 2-fold 
greater than the IP3-phosphatase found in this 
fraction (fig, 4A). Half-maximal hydrolysis of IP2 
was obtained at a concentration of 0.8 /cM. 
The apparent Km of the IP3 phosphatase present 
in the erythrocyte membrane has been reported to 
be 25 ,uM [7], which is substantially higher than we 
find for the liver enzyme. Nevertheless, in many 
respects the two enzymes display identical proper- 
ties. This applies to their pH optima, Mg2+ 
dependence and selective hydrolysis of the 
S-phosphate on the inositol ring. Our findings are 
in qualitative agreement with a recent study of IP3 
hydrolysis in liver reported by Seyfred et al. [20]. 
At present, it cannot be excluded that the soluble 
form of the IP3 phosphatase (table 1, fig. 4A) does 
not arise from the dissociation of the plasma mem- 
brane enzyme during subcellular fractionation. It 
is clear, however, that the greater portion of this 
activity is located in the plasma membrane. If this 
result can be extrapolated to the intact cell, the 
conclusion can be drawn that the plasma mem- 
brane is both the site of production and degrada- 
tion of this messenger molecule. However, Ca2+ 
release promoted by IP3 occurs from a specialized 
part of the hepatic endoplasmic reticulum [3]. 
Presumably, IP3 reaches this site as a consequence 
of diffusion from the plasma membrane. Very lit- 
tle is known concerning the exact location of the 
IP3-releasable Ca2+ store within the cell or the dif-. 
fusion properties of IP3. The rapidity with which 
hormones can cause the internal mobilization of 
Ca2+ prompts the speculation that the IP3-sensitive 
Ca2+ store may also lie in close proximity to the 
plasma membrane. 
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